|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Pathfinder Cell Therapy, Inc. Provides Update on Pathfinder Cell Research and Development
12/13/2011 9:36:37 AM
CAMBRIDGE, Mass., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB:PFND), a biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today provided a progress update on its research and development activities for the Company's proprietary Pathfinder Cells ("PCs"). In multiple animal models, Pathfinder has confirmed the ability of PCs to stimulate the natural regeneration of surrounding damaged tissues without the cells being incorporated into the newly generated tissue. These positive preliminary data support further development of PCs as a potential treatment for several important human diseases including diabetes, cardiac ischemia, and renal reperfusion injury.
|
|
|
|
|
|
|
|
|
|
|